| MDxHealth S.A.. (2/19/19). "Press Release: MDxHealth Appoints Michael K. McGarrity as CEO. Dr. Jan Groen Continues as an Advisor to the Board". Irvine, CA & Herstal. |
2019-02-19 |
| MorphoSys AG. (2/19/19). "Press Release: Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire". Planegg. |
2019-02-19 |
| GT Gain Therapeutics S.A.. (2/19/19). "Press Release: Gain Therapeutics SA Announces Closing of EU 2.5 Million Series A Financing to Develop Novel Brain-Penetrant Non-Competitive Pharmacological Chaperones for Rare Lysosomal Storage Diseases and CNS Indi |
2019-02-19 |
| Nabriva Therapeutics plc. (2/19/19). "Press Release: Nabriva Therapeutics Announces Acceptance of New Drug Applications by the FDA for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults". Dublin. |
2019-02-19 |
| S-Biomedic N.V.. (2/18/19). "Press Release: Microbiome Pioneer S-Biomedic Completes Series A Round with DSM Venturing". Belgium. |
2019-02-18 |
| Curetis N.V.. (2/18/19). "Press Release: Curetis’ Subsidiary Ares Genetics and Qiagen Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance". Vienna, Holzgerlingen & Amsterdam. |
2019-02-18 |
| Merck KGaA. (2/16/19). "Press Release: Pivotal Phase III Data for Bavencio (avelumab) plus Inlyta (axitinib) in Advanced Renal Cell Carcinoma Published in The New England Journal of Medicine [Not intended for US, Canada and UK-based media]". Darmstadt & |
2019-02-16 |
| Bayer AG / Bayer Corporation. (2/15/19). "Press Release: Bayer to Obtain Full Rights to Global Development and Commercialization of Oncology Compounds Vitrakvi (larotrectinib) and BAY 2731954 (LOXO-195)". Whippany, NJ. |
2019-02-15 |
| UCB S.A.. (2/15/19). "Press Release: UCB Builds on Its R&D Footprint to Form a Research Satellite Facility within King’s College London". Brussels & Slough. |
2019-02-15 |
| Hookipa Pharma Inc.. (2/15/19). "Press Release: Hookipa Appoints Michael A. Kelly as Independent Director". New York, NY & Vienna. |
2019-02-15 |
| Sygnature Discovery Ltd.. (2/15/19). "Press Release: Sygnature Discovery Starts 2019 with Two Senior Appointments – Dr Allan Jordan and Ms Louisa Jordison". Nottingham. |
2019-02-15 |
| Arvelle Therapeutics GmbH. (2/14/19). "Press Release: Newly-Formed Arvelle Therapeutics Acquires Exclusive Rights from SK Biopharmaceuticals to Develop and Commercialize Cenobamate in Europe". Basel. |
2019-02-14 |
| High-Tech Gründerfonds Management GmbH. (2/14/19). "Press Release: Plasmion’ SICRIT Sensor Technology Convinces Investors". |
2019-02-14 |
| AbCellera Biologics, Inc.. (2/14/19). "Press Release: AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma". Vancouver, BC. |
2019-02-14 |
| InflaRx N.V.. (2/14/19). "Press Release: Richard Brudnick to Join InflaRx Board of Directors". Jena. |
2019-02-14 |
| BioMed X GmbH. (2/14/19). "Press Release: Merck and BioMed X Expand Collaboration to Immunology Research". Heidelberg. |
2019-02-14 |
| Lonza Group AG. (2/13/19). "Press Release: Emerald Health Pharmaceuticals and Lonza Announce Agreement for Manufacturing of Novel Cannabinoid-Derived Drug Candidate". San Diego, CA & Basel. |
2019-02-13 |
| Charles River Laboratories International, Inc.. (2/13/19). "Press Release: Charles River Laboratories Signs Binding Offer to Acquire CiToxLab". Wilmington, MA. |
2019-02-13 |
| Novartis AG. (2/13/19). "Press Release: Novartis Receives FDA Approval for Egaten for the Treatment of Fascioliasis, a Neglected Tropical Disease". Basel. |
2019-02-13 |
| Genedata AG. (2/12/19). "Press Release: Genedata Releases New Request Management System for Biotherapeutics R&D Processes". Basel. |
2019-02-12 |
| Evonik Industries AG. (2/12/19). "Press Release: Evonik more than Doubles Venture Capital to Accelerate Innovation. Evonik Has Launched Its Second Venture Capital Fund with a Volume of €150 Millionmillion". Essen. |
2019-02-12 |
| Sanofi S.A.. (2/12/19). "Press Release: Sanofi Appoints Ameet Nathwani Chief Digital Officer". Paris. |
2019-02-12 |
| Boehringer Ingelheim (Canada) Ltd.. (2/12/19). "Press Release: Boehringer Ingelheim (Canada) Ltd. and IBM Canada Announce First of its Kind Collaboration to Integrate Blockchain Technology into Clinical Trials". Burlington, ON & Markham, ON. |
2019-02-12 |
| Bruker Corporation. (2/11/19). "Press Release: Bruker Reports Fourth Quarter and Fiscal Year 2018 Financial Results". Billerica, MA. |
2019-02-11 |
| Lonza Group AG. (2/11/19). "Press Release: Lonza’s New Pooled Donor Suspension Hepatocytes Enable the Next Level of Reliability, Robustness and Customizability". Walkersville, MD & Basel. |
2019-02-11 |
| Grey Wolf Therapeutics Ltd.. (2/11/19). "Press Release: Grey Wolf Therapeutics Completes £10 Million ($14 Million) Series A Financing". Oxford. |
2019-02-11 |
| Merck KGaA. (2/11/19). "Press Release: FDA Accepts sBLA and Grants Priority Review for Bavencio (avelumab) plus Inlyta (axitinib) for the Treatment of Advanced Renal Cell Carcinoma [Not intended for US, Canada and UK-based media]". Darmstadt. |
2019-02-11 |
| Medigene AG. (2/11/19). "Press Release: Medigene Appoints Axel-Sven Malkomes as CFO/CBDO". Martinsried. |
2019-02-11 |
| Eurofins. (2/11/19). "Press Release: New Site for Microbiology and DNA Analysis in Bremerhaven. Q-Bioanalytic Strengthens the Eurofins Laboratory Network". |
2019-02-11 |
| Follicum AB. (2/11/19). "Press Release: Follicum Selects Novel Peptide Drug Candidate for the Treatment of Diabetes and Protection of Beta Cells". |
2019-02-11 |
| Spectro Analytical Instruments GmbH. (2/11/19). "Press Release: Spectro Introduces SpectroGreen ICP-OES Analyzer". |
2019-02-11 |
| UCB S.A.. (2/11/19). "Press Release: UCB and Epilepsy Society Announce Pioneering UK Genomics R&D collaboration". Slough & Brussels. |
2019-02-11 |
| Uniqure N.V.. (2/8/19). "Press Release: Uniqure Announces Updated Clinical Data from Phase IIb Study of AMT-061 in Patients with Hemophilia B". Lexington, MA & Amsterdam. |
2019-02-08 |
| Symrise AG. (2/8/19). "Press Release: Symrise Successfully Completes Capital Increase. Strong Investor Demand – 5.614 Million New Shares Placed – Gross Proceeds amount of € 400 Million [Not for US, CA, AU or JP]". |
2019-02-08 |
| Vita 34 AG. (2/8/19). "Press Release: Vita 34 Develops Cell Preparations as the Source Material for Immune Cell Therapies and Becomes Cell Bank". Leipzig. |
2019-02-08 |
| Fluidigm Corporation. (2/7/19). "Press Release: Fluidigm Announces Participation in Life Science/Pharma and Academic Consortium to Study T Cell-Driven Immune-Mediated Inflammatory Diseases". South San Francisco, CA. |
2019-02-07 |
| Lunaphore Technologies S.A.. (2/7/19). "Press Release: Lunaphore Launches Its First Product LabSat". Lausanne. |
2019-02-07 |
| Fluidigm Corporation. (2/7/19). "Press Release: Fluidigm Announces Fourth Quarter and Full Year 2018 Financial Results". South San Francisco, CA. |
2019-02-07 |
| bioMérieux S.A.. (2/7/19). "Press Release: bioMérieux Acquires Invisible Sentinel, a US-based Company Specialized in Food and Beverage Molecular Testing". Marcy l’Étoile. |
2019-02-07 |
| Evotec AG. (2/7/19). "Press Release: Evotec Mourns Loss of Company Co-founder Prof. Manfred Eigen". Hamburg. |
2019-02-07 |
| Sanofi S.A.. (2/7/19). "Press Release: Sanofi Delivers 2018 Business EPS Growth of 5.1% at CER". Paris. |
2019-02-07 |
| OSE Immunotherapeutics S.A.. (2/7/19). "Press Release: OSE Immunotherapeutics and Servier Announce First Option within Global License Agreement Exercised for further Clinical Development and Potential Commercialisation of OSE-127 in Autoimmune Diseases". |
2019-02-07 |
| Oxford BioMedica plc. (2/7/19). "Press Release: Oxford Biomedica Provides Update on Programmes Outlicensed to Sanofi". Oxford. |
2019-02-07 |
| Altona Diagnostics GmbH. (2/7/19). "Press Release: Altona Diagnostics Receives CE-IVD Mark for HCV RT-PCR Test". Hamburg. |
2019-02-07 |
| Sygnature Discovery Ltd.. (2/7/19). "Press Release: Pathios Therapeutics and Sygnature Discovery Sign a Strategic and Innovative Partnership to Develop First in Class Therapies in Autoimmune Disease and Immuno-oncology". Oxford & Nottingham. |
2019-02-07 |
| HiberCell Inc.. (2/7/19). "Press Release: HiberCell Launches to Prevent Cancer Relapse and Metastasis with Novel Therapeutics. $60.75M Funding Round Led by ARCH Venture Partners with 6 Dimensions Capital". New York, NY. |
2019-02-07 |
| Evotec AG. (2/7/19). "Press Release: Evotec and Galapagos Enter into Collaboration in the Field of Fibrosis". Hamburg & Mechelen. |
2019-02-07 |
| Grifols S.A.. (2/7/19). "Press Release: Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System". Barcelona. |
2019-02-07 |
| Sanofi S.A.. (2/6/19). "Press Release: FDA Approves Cablivi (caplacizumab-yhdp), the First Nanobody-based Medicine, for Adults with Acquired Thrombotic Thrombocytopenic Purpura (aTTP)". Paris. |
2019-02-06 |
| InflaRx N.V.. (2/6/19). "Press Release: InflaRx Announces Presentation of New Clinical Data with Lead Candidate IFX-1 in Hidradenitis Suppurativa". Jena. |
2019-02-06 |
| Merck KGaA. (2/6/19). "Press Release: Merck to Expand US Biopharmaceutical R&D Facility to Advance Innovative Clinical Pipeline". Darmstadt. |
2019-02-06 |
| Andrew Alliance S.A.. (2/6/19). "Press Release: Andrew Alliance and Waters Corporation Partner to Provide Tailored Tools for LC-MS Research". |
2019-02-06 |
| Roche. (2/6/19). "Press Release: Roche Joins the World Federation of Hemophilia Humanitarian Aid Program". Basel. |
2019-02-06 |
| GlaxoSmithKline plc. (2/6/19). "Press Release: GSK Delivers Sales, Earnings and Cash Flow Growth in 2018". London. |
2019-02-06 |
| Sanofi S.A.. (2/6/19). "Press Release: Sanofi’s Board of Directors Notes the Resignation of Christian Mulliez and Co-opts Christophe Babule as Director". Paris. |
2019-02-06 |
| Rewind Therapeutics. (2/6/19). "Press Release: Rewind Therapeutics Expands Scientific Advisory Board with Addition of Professors Robin Franklin and Catherine Lubetzki, Bringing further Expertise in Myelin and Multiple Sclerosis Research". Leuven. |
2019-02-06 |
| MacroGenics, Inc.. (2/6/19). "Press Release: MacroGenics Announces Positive Results from Pivotal Phase 3 SOPHIA Study of Margetuximab". Rockville, MD. |
2019-02-06 |
| 4SC AG. (2/6/19). "Press Release: First Patient Enrolled in Phase II Study EMERGE of Domatinostat (4SC-202) in Gastrointestinal Cancer". Planegg-Martinsried. |
2019-02-06 |
| Genedata AG. (2/5/19). "Press Release: Genedata Announces Bruker as a New Ready-to-Run Partner". Washington, DC. |
2019-02-05 |
| Xencor, Inc.. (2/5/19). "Press Release: Xencor to Develop and Commercialize Novel IL-15 Immune Activating Cytokines with Genentech". Monrovia, CA. |
2019-02-05 |
| ProteoNic Biotechnology B.V.. (2/5/19). "Press Release: ProteoNic Biotechnology Licenses Protein Production Technology to Eli Lilly and Company". Leiden. |
2019-02-05 |
| MorphoSys AG. (2/5/19). "Press Release: MorphoSys Announces Appointment of David Trexler as President and Member of the Board of Directors of MorphoSys US Inc.". Planegg. |
2019-02-05 |
| Sanofi S.A.. (2/5/19). "Press Release: Isatuximab Phase 3 Trial Meets Primary Endpoint of Prolonging Progression Free Survival in Patients with Relapsed/Refractory Multiple Myeloma". Paris. |
2019-02-05 |
| CureVac AG. (2/4/19). "Press Release: CureVac Appoints Stefan Mueller, Ph.D., as Vice President Preclinical". Tübingen & Boston, MA. |
2019-02-04 |
| Qiagen N.V.. (2/4/19). "Press Release: Qiagen Informatics Solutions Chosen to Support Genomics England’s Bold Five Million Genomes in Five Years Project". Hilden & London. |
2019-02-04 |
| Genedata AG. (2/4/19). "Press Release: New Web-based Genedata Screener Showcases at SLAS2019". Washington, DC. |
2019-02-04 |
| Argen-X N.V. (Argenx). (2/4/19). "Press Release: Argenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE Technology". Breda, Ghent & San Diego, CA. |
2019-02-04 |
| Andrew Alliance S.A.. (2/4/19). "Press Release: Macherey-Nagel GmbH & Co. KG and Andrew Alliance Sign Co-Marketing Agreement". Geneva. |
2019-02-04 |
| Avacta Group plc. (2/4/19). "Press Release: Moderna Exercises Option for an Exclusive Product License". |
2019-02-04 |
| Follicum AB. (2/4/19). "Press Release: Follicum’s New Topical Formulation of FOL-005 Results in Increased Hair Growth on a Par with Leading Commercial Product". |
2019-02-04 |
| Sosei Group Corporation (d/b/a Sosei Heptares). (2/4/19). "Press Release: Sosei Heptares Announces Medicxi to Invest up to €40 Million in New Collaboration Based on Its Orexin Agonist Program". Tokyo & London. |
2019-02-04 |
| Sanofi S.A.. (2/4/19). "Press Release: CHMP Recommends Approval of Praluent (alirocumab) to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease". Paris & Tarrytown, NY. |
2019-02-04 |
| Qiagen N.V.. (2/4/19). "Press Release: Qiagen Reports Results for Fourth Quarter and Full-year 2018". Venlo. |
2019-02-04 |
| ETH Zürich [Florian Meyer]. (2/4/19). "Press Release: Promoting Talents and New Ideas for Food Systems of the Future". |
2019-02-04 |
| [iito] Business Intelligence. (2/1/19). "Press Release: [iito] Web Portals Surpass Half a Million Page Views per Month". Bremen. |
2019-02-01 |
| Memo Therapeutics AG. (2/1/19). "Press Release: Memo Therapeutics Announces the Development of a Droplet Sorter Enabling Functional Antibody Screening in a High-Throughput Format". |
2019-02-01 |
| Apceth Biopharma GmbH. (1/31/19). "Press Release: Hitachi Chemical Co. Ltd. to Acquire Apceth Biopharma GmbH". Munich. |
2019-01-31 |
| Bayer AG. (1/31/19). "Press Release: Bayer and Kyoto University Form Research Alliance to Discover New Treatment Approaches against Lung Diseases [Not intended for U.S. and UK Media]". Berlin. |
2019-01-31 |
| MeiraGTx Holdings plc. (1/31/19). "Press Release: MeiraGTx Enters into Strategic Collaboration with Janssen to Develop and Commercialize Gene Therapy Treatments for Inherited Retinal Diseases". London & New York, NY. |
2019-01-31 |
| Hitachi Chemical Co., Ltd.. (1/31/19). "Press Release: Notice Regarding the Stock Acquisition of Apceth Biopharma GmbH, a Contract Manufacturer of Regenerative Medicine Products". |
2019-01-31 |
| Roche. (1/31/19). "Press Release: Roche Reports Very Strong Results in 2018. Group Sales Increase 7% at Constant Exchange Rates and in Swiss Francs". Basel. |
2019-01-31 |
| MorphoSys AG. (1/31/19). "Press Release: MorphoSys Announces Settlement in Patent Lawsuit with Janssen and Genmab". Planegg. |
2019-01-31 |
| Symrise AG. (1/31/19). "Press Release: Symrise Strengthens Pet Food Activities and Expands US Footprint with Acquisition of ADF/IDF". |
2019-01-31 |
| Sanofi S.A.. (1/30/19). "Press Release: Fexinidazole, the First All-oral Treatment for Sleeping Sickness, Approved in Democratic Republic of Congo". Paris & Geneva. |
2019-01-30 |
| Beckman Coulter Life Sciences. (1/30/19). "Press Release: Beckman Coulter Life Sciences Acquires Labcyte to Expand Laboratory Automation Business". Indianapolis, IN. |
2019-01-30 |
| Dewpoint Therapeutics. (1/30/19). "Press Release: Dewpoint Therapeutics Launches with $60 Million Series A to Advance Proprietary Platform for Drugging Condensates". Cambridge, MA. |
2019-01-30 |
| Roche. (1/30/19). "Press Release: Roche to Discontinue Phase III CREAD 1 and 2 Clinical Studies of Crenezumab in Early Alzheimer’s Disease (AD) - other Company Programmes in AD Continue". Basel. |
2019-01-30 |
| Orphazyme A/S. (1/30/19). "Press Release: Orphazyme Reports Positive Results from Full Data Set of Phase II/III Arimoclomol Tria in Niemann-Pick Disease Type C (NPC)". Copenhagen. |
2019-01-30 |
| Curetis N.V.. (1/30/19). "Press Release: Curetis’ Unyvero Application Cartridges Receive Regulatory Approvals in Malaysia and Thailand". Amsterdam & Holzgerlingen. |
2019-01-30 |
| Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Sets Offer Price at 75 Euro per Share (Adhoc-News)". |
2019-01-29 |
| Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Announces Strong Investor Demand and Expected Offer Price (Adhoc-News)". |
2019-01-29 |
| BioStrata Ltd.. (1/29/19). "Press Release: BioStrata Announces New Hires to Drive Continued Growth across Its Specialist Marketing Communications Offering". Cambridge. |
2019-01-29 |
| Horizon Discovery Group plc. (1/28/19). "Press Release: Horizon Discovery and Rutgers University Form Exclusive Partnership to Develop Next Generation Novel Gene Editing Technology". Cambridge. |
2019-01-28 |
| CureVac AG. (1/28/19). "Press Release: CureVac Appoints Dimitris Voliotis, M.D., Dr. med., as Chief Development Officer". Tübingen & Boston, MA. |
2019-01-28 |
| Optibrium Ltd.. (1/28/19). "Press Release: Optibrium Strengthens Senior Management Team with Financial Director Appointment". Cambridge. |
2019-01-28 |
| Allogene Therapeutics, Inc.. (1/28/19). "Press Release: Allogene Therapeutics, in Collaboration with Servier, Announces FDA Clearance of the IND for ALLO-501, an anti-CD19 Allogeneic CAR T (AlloCAR T™) Therapy". South San Francisco, CA & Paris. |
2019-01-28 |
| MorphoSys AG. (1/26/19). "Press Release: MorphoSys Announces That Its Patents Were Ruled Invalid in Patent Lawsuit Against Janssen and Genmab (Ad hoc)". Planegg. |
2019-01-26 |
| Genmab A/S. (1/26/19). "Press Release: Genmab Announces that the Patents Asserted against Darzalex in the United States Have Been Declared Invalid by Summary Judgment". Copenhagen. |
2019-01-26 |
| MaSTherCell Global, Inc.. (1/25/19). "Press Release: Great Point Partners-backed Strategic Partner MaSTherCell Global Announces Achievement of First Milestone Funding and Expansion with New Facility in Houston, Texas". Greenwich, CT & Houston, TX. |
2019-01-25 |
| Genomics England Ltd.. (1/25/19). "Press Release: Jonathan Symonds Appointed New Chair of Genomics England". |
2019-01-25 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo-2011.jpg){kind=logo}
1 2 3 4 ... 167 168 169 
Date![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lsus-life-sciences-usa-com-beta.jpg)
![Picture [iito] LSUS iitoLifeScience Transatlantic Life Sciences 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
